Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series - Top-Institutions - MDSpire

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series

  • By

  • Giulia Odorici

  • Cinzia Buligan

  • Carolina Fantini

  • Lucia Mantovani

  • Giulia Rech

  • Lidia Sacchelli

  • July 14, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    SIDeMaST (Italian Society of Dermatology and Sexually transmitted Diseases)
    SIDeMaST (Italian Society of Dermatology and Sexually transmitted Diseases)

    Rome, Lazio

    Key Differentiators

    • Dermatology

  • #2

    CorEvitas Psoriasis Registry
    CorEvitas Psoriasis Registry

    N/A, N/A

    Key Differentiators

    • Dermatology

  • #3

    Wilford Hall Ambulatory Surgical Center
    Wilford Hall Ambulatory Surgical Center

    San Antonio, Texas

    Key Differentiators

    • Dermatology

  • #4

    Tertiary Referral Hospital
    Tertiary Referral Hospital

    N/A, N/A

    Key Differentiators

    • Dermatology

Original Source(s)

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series

  • by Giulia Odorici, Cinzia Buligan, Carolina Fantini, Lucia Mantovani, Giulia Rech, Lidia Sacchelli

  • July 14, 2026

Related Content

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study

Mental Health May Impact Dermatologic Quality of Life

Poorer dermatology-related quality of life was associated with greater mental health issues, while habitual probiotic intake showed no measurable relationship with these outcomes.

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics